METHYLPHENIDATE HYDROCHLORIDE
NDC 75834-324, METHYLPHENIDATE HYDROCHLORIDE, tablet, from Nivagen Pharmaceuticals, Inc..
- Product NDC
- 75834-324
- Status
- Listed
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208737
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/75834-324 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75834-324-01 | 75834032401 | 100 TABLET in 1 BOTTLE (75834-324-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4cc16009-44ad-4055-ac76-efa282f1ff47NADAC price for package 75834032401
GET /v1/drugs/nadac/75834032401
Use it
Look up 75834-324 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75834-324 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75834-324. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.